| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Sign In to gain access to subscriptions and/or personal tools.
|
|
|
|||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
SYMPOSIUM |
From the Division of Endocrinology, Diabetes, and Hypertension, SUNY Downstate Medical Center, Kings County Hospital Center, and VA New York Harbor Healthcare System, Brooklyn Campus, Brooklyn, New York.
The incidence of diabetes mellitus, particularly type 2 diabetes, is increasing dramatically in the United States and in other Westernized, industrialized societies because of increasing obesity, sedentary lifestyle, and population aging. There are currently 20 million persons with diabetes in the United States, of whom more than 5 million remain undiagnosed. The diabetic population consumes a disproportionate share of health care resources because of both microvascular and macrovascular complications. Diabetes is a major cause of new-onset blindness, end-stage renal disease, and nontraumatic amputation in the United States. Cardiovascular disease accounts for up to 80% of premature excess mortality in diabetic patients. Strategies to lessen the disease burden in these patients include hygienic measures (diet and exercise) as well as rigorous treatment of hypertension, dyslipidemia, and hyperglycemia.
Key Words: Type 2 diabetes • cardiovascular disease • health care • obesity • morbidity • mortality
Address for reprints: Nathaniel Winer, MD, Division of Endocrinology, Diabetes, and Hypertension, Box 1205, SUNY Downstate Medical Center, Kings County Hospital Center, and VA New York Harbor Healthcare System, Brooklyn Campus, 450 Clarkson Avenue, Brooklyn, NY 11203-2098.
This article has been cited by other articles:
|
|
 |
|
  T. M.E. Davis, J. Beilby, W. A. Davis, J. K. Olynyk, G. P. Jeffrey, E. Rossi, C. Boyder, and D. G. Bruce Prevalence, Characteristics, and Prognostic Significance of HFE Gene Mutations in Type 2 Diabetes: The Fremantle Diabetes Study Diabetes Care, September 1, 2008; 31(9): 1795 - 1801. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Hansen, R. J. Clarke, K. A. Buhagiar, E. Hamilton, A. Garcia, C. White, and H. H. Rasmussen Alloxan-induced diabetes reduces sarcolemmal Na+-K+ pump function in rabbit ventricular myocytes Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1070 - C1077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gkaliagkousi, A. Shah, and A. Ferro Review: Pharmacological and non-pharmacological treatment of endothelial dysfunction: relevance to diabetes The British Journal of Diabetes & Vascular Disease, January 1, 2007; 7(1): 5 - 10. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Halaschek-Wiener and A. Brooks-Wilson Progeria of Stem Cells: Stem Cell Exhaustion in Hutchinson-Gilford Progeria Syndrome J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2007; 62(1): 3 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Gomez-Pinilla, C. Camello-Almaraz, R. Moreno, P. J. Camello, and M. J. Pozo Melatonin Treatment Reverts Age-Related Changes in Guinea Pig Gallbladder Neuromuscular Transmission and Contractility J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 847 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. P. Dobesh Managing hypertension in patients with type 2 diabetes mellitus. Am. J. Health Syst. Pharm., June 15, 2006; 63(12): 1140 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Slaughter Hemostasis and glycemic control in the cardiac surgical patient. Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2006; 10(2): 176 - 179. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Chen, J.-h. Ding, R. Bekeredjian, B.-z. Yang, R. V. Shohet, S. A. Johnston, H. E. Hohmeier, C. B. Newgard, and P. A. Grayburn Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology PNAS, May 30, 2006; 103(22): 8469 - 8474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Lacroix, V Aboyans, M. Criqui, F Bertin, T Bouhamed, F Archambeaud, and M Laskar Type-2 diabetes and carotid stenosis: a proposal for a screening strategy in asymptomatic patients Vascular Medicine, May 1, 2006; 11(2): 93 - 99. [Abstract] [PDF]
|
|
|
|
 |
|
 E. Sugaru, T. Nakagawa, M. Ono-Kishino, J. Nagamine, T. Tokunaga, M. Kitoh, W. E. Hume, R. Nagata, and M. Taiji SMP-534 ameliorates progression of glomerular fibrosis and urinary albumin in diabetic db/db mice Am J Physiol Renal Physiol, April 1, 2006; 290(4): F813 - F820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. H Barnett The challenge of tackling cardiovascular outcomes The British Journal of Diabetes & Vascular Disease, March 1, 2006; 6(2_suppl): S12 - S16. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Lupi, S. D. Guerra, M. Bugliani, U. Boggi, F. Mosca, S. Torri, S. D. Prato, and P. Marchetti The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets Eur. J. Endocrinol., February 1, 2006; 154(2): 355 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cusick, A. D. Meleth, E. Agron, M. R. Fisher, G. F. Reed, G. L. Knatterud, F. B. Barton, M. D. Davis, F. L. Ferris III, E. Y. Chew, et al. Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study report no. 27 Diabetes Care, March 1, 2005; 28(3): 617 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Prisant Diabetes Mellitus: An Imperative for Prevention and Intense Management J. Clin. Pharmacol., April 1, 2004; 44(4): 394 - 396. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
